Scynexis Inc (NASDAQ: SCYX)

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic CIK: 0001178253
Market Cap 39.45 Mn
P/E -4.65
P/S 1.92
Div. Yield 0.00
Revenue Growth (1y) (Qtr) 1,808.50
Add ratio to table...

About

SCYNEXIS INC (SCYX) is a biopharmaceutical company that operates in the healthcare and life sciences industry. Its primary business activities revolve around the development of a proprietary antifungal platform, which includes a novel class of antifungal agents called triterpenoids. The company's main focus is to create innovative medicines that can overcome and prevent difficult-to-treat and drug-resistant infections. SCYNEXIS INC generates revenue primarily through licensing agreements and collaborations with other companies. A significant development...

Read more

Product and Service Breakdown of Revenue (2025)

Statement of Income Location, Balance Breakdown of Revenue (2025)

Peer comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TAK Takeda Pharmaceutical Co Ltd 202.50 Bn 40.69 6.74 27.43 Bn
2 ZTS Zoetis Inc. 51.58 Bn 19.29 5.45 9.04 Bn
3 TEVA Teva Pharmaceutical Industries Ltd 32.45 Bn 22.85 1.88 16.81 Bn
4 UTHR UNITED THERAPEUTICS Corp 26.06 Bn 19.51 8.19 -
5 ACB Aurora Cannabis Inc 15.01 Bn 93.81 -2,482.90 0.04 Bn
6 NBIX Neurocrine Biosciences Inc 12.80 Bn 26.69 4.47 -
7 HCM HUTCHMED (China) Ltd 12.21 Bn 26.85 22.27 0.09 Bn
8 ELAN Elanco Animal Health Inc 11.64 Bn -49.87 2.47 4.02 Bn